Is This Just A Random Move? – The Carlyle Group L.P. (CG), Incyte Corporation (INCY)

The Carlyle Group L.P. (NASDAQ:CG) shares were trading lower by 0 percent ($0) at $20.55 a piece in Tuesday’s session. It had closed the previous session at $20.55. CG trades with a P/S ratio of 2.12. This is lower than the both industry’s 9.46 and the wider sector’s 6.01. A low price-to-sales ratio, typically less than 1.0, is considered a good value. Also, it has an estimated price-earnings (P/E) multiple of 8.34 and a trailing 12-month price-earnings (P/E) multiple of 11.31. Shares of CG have downtrended -0.72% in the past three months, while the S&P 500 has moved -8.18% in that time. The Carlyle Group L.P. (CG) has a market cap of $7.05 billion and over the last 12 months, The Carlyle Group L.P. (NASDAQ:CG) has gone stronger by 38.91%. During the last 52 weeks, the (NASDAQ:CG) price has been as high as $24.85 and as low as $14.55. The Carlyle Group L.P. earnings have declined with an annualized rate of -18.83% over the last 5 years.

The Carlyle Group L.P. (Mean Target Price: $26)

The average 1-year price target for The Carlyle Group L.P. (CG) — averaging the work of different analysts — reveals a mean PT of $26/share. That’s a potential 26.52 increase relative to where The Carlyle Group L.P. (NASDAQ:CG) has been trading recently. The current price is seen ranging between $20.45 and $20.8. There are brokerage firms with lower targets than the average, including one setting a price target of $22. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $31.

The Carlyle Group L.P. (CG) Consensus Recommendation

The collective rating of 2.3 for The Carlyle Group L.P. (NASDAQ:CG) also leans strongly towards the neutral end of the spectrum. Of the 12 analysts surveyed by Reuters that track CG 5 of them rate its stock a hold. The other 7, though not evenly; between analysts who think you should buy The Carlyle Group L.P. versus those who think you should sell it. A 7 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of CG or, if they already own its stock, sell it.

Is Incyte Corporation (NASDAQ:INCY) Cheap From Peers?

Incyte Corporation (INCY) pulled off a 0.03 percent gain and now trades for $93.71. INCY comes in with a P/S ratio of 13.51 that’s greater than 1, potentially implying that it could be expensive relative to the overall sector (5.64) and its peers (100.97). Also, it has an estimated price-earnings (P/E) multiple of 470.9 . During the last 52 weeks, the price has been as high as $153.15 and as low as $93.65. Incyte Corporation (NASDAQ:INCY) earnings have risen with a quarterly rate of 63.6% over the last 5 years. Shares of INCY have sank -31.02% in the past three monthswhile the S&P 500 has dropped -36.32% in that time.

Incyte Corporation (Price Objective: $147.74)

Incyte Corporation (NASDAQ:INCY) has a market cap of $19.17 billion and over the last 12 months, INCY has declined by -10.55%. The average 1-year price target for (INCY) reveals an average price target of $147.74 per share. That’s a potential 57.66 gain from where (NASDAQ:INCY) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $120. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $173.

Analyst Thoughts About Incyte Corporation (NASDAQ:INCY)

The consensus recommendation — averaging the work of 21 analysts — of 2 for Incyte Corporation (INCY) points to moderate case. Of the analysts surveyed by Reuters that track Incyte Corporation 4 of them rate its stock a hold. The other 17 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 17 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:INCY) or, if they already own its stock, sell it.